| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.09 | 0.007 |